The correlation between breast cancer and Parkinson's disease: A meta-analysis

Cun Liu; Cun Liu; Lu Wang; Lu Wang; Jinhui Tian; Jinhui Tian; Lijuan Liu; Lijuan Liu; Linxiang Guo; Linxiang Guo; Guowen Ge; Guowen Ge; Liang Zheng; Liang Zheng; Fubin Feng; Fubin Feng; Jinmei Zhang; Jinmei Zhang; Tingting Zhang; Tingting Zhang; Changgang Sun; Changgang Sun

doi:10.18632/oncotarget.24199

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Withdrawal Notice

This paper was originally published in Oncotarget Advance Online Publications on 01/12/2018.
In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.

Research Papers:

The correlation between breast cancer and Parkinson's disease: A meta-analysis

Cun Liu _, Cun Liu, Lu Wang, Lu Wang, Jinhui Tian, Jinhui Tian, Lijuan Liu, Lijuan Liu, Linxiang Guo, Linxiang Guo, Guowen Ge, Guowen Ge, Liang Zheng, Liang Zheng, Fubin Feng, Fubin Feng, Jinmei Zhang, Jinmei Zhang, Tingting Zhang, Tingting Zhang, Changgang Sun and Changgang Sun _

Cun Liu1,*, Lu Wang1,* Jinhui Tian2, Lijuan Liu3, Linxiang Guo4, Guowen Ge5, Liang Zheng6, Fubin Feng3, Jinmei Zhang7, Tingting Zhang1 and Changgang Sun3,8

1 College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, PR China

2 Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, PR China

3 Department of Oncology, Weifang Traditional Chinese Hospital, Weifang, Shandong Province, PR China

4 School of Foreign Language Education, Qingdao University, Qingdao, Shandong, PR China

5 Clinical College, Weifang Medical University, Weifang, Shandong, PR China

6 Department of Cardiovascular Medicine, Research Center for Translational Medicine, Dongfang Hospital, Tongji University, Shanghai, PR China

7 Department of Endocrinology, Weifang Traditional Chinese Hospital, Weifang, Shandong, PR China

8 Department of Oncology, Affilited Hospital of Weifang Medical University, Weifang, Shandong, PR China

* Cun Liu and Lu Wang contributed equally to this paper and are co-first authors

Correspondence to:

Changgang Sun, email: [email protected]

Keywords: breast cancer; Parkinson’s disease; meta-analysis; risk

Received: October 11, 2017 Accepted: December 05, 2017 Epub: January 12, 2018

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24199

Publication Alerts

Withdrawal Notice

Research Papers:

The correlation between breast cancer and Parkinson's disease: A meta-analysis